Adverse Events, Comorbidities, and HIV
The Latest
IAS 2019: What to Expect in HIV Science
Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
This Week in HIV Research: Cracking the Contraception Conundrum
July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.
This Week in HIV Research: Weighing Anchor on NRTI-Free Treatment
June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.
Underwhelming Results From Hepatitis C Vaccine Trial
The 548-person U.S. study found that chronic hepatitis C infection occurred among an identical number of people who received the experimental vaccine compared to people who received a placebo.
This Week in HIV Research: One Step at a Time
June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.
CDC Study Reinforces the Importance of Annual STI Testing Among MSM
Rectal and throat tests matter too, and providers should be recommending them.
This Week in HIV Research: Matters of the Heart
May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.
FDA Approves First Throat and Rectal Tests for Detecting Chlamydia and Gonorrhea
These two tests make it easier to diagnose sexually transmitted infections that often go untreated.
This Week in HIV Research: I Screen, You Screen, We All Screen for HPV-Related Cancers
May 23, 2019: How CD4 variables over time affect anal cancer risk; when to consider anal pap smears for women; switching from E/C/F/TAF to ABC/3TC; new data on marijuana use among people with HIV.
Researchers Recommend Screening All People With HIV for Elevated Liver Function Values
Authors of a literature review note the high prevalence of liver disease among people with HIV and recommend a step-by-step approach to management.